Life Sciences & Healthcare
Regulation of medicines, medical devices, health facilities and health data in Kenya, from Pharmacy and Poisons Board approvals to the Digital Health Act, 2023.
Exit Strategies for Life Sciences Investors in Kenya: M&A, IPO and Trade Sale Compared
Exit strategies for life sciences investors in Kenya rarely follow a single template. A private equity fund, venture investor or strategic partner that backed…
8 Sep 2026, 6 min readRead the article
Cross-Border Licensing Deals: What Multinational Pharma Should Know About Kenyan Contract Law
8 Sep 2026, 6 min read
Listing on NSE GEMS: A Capital-Raising Option for Kenyan Health-Tech Companies
3 Sep 2026, 6 min read
Manufacturing and Supply Agreements for Pharmaceutical Companies Operating in Kenya
3 Sep 2026, 6 min read
From Trial to Market: Structuring Sponsor-Site Clinical Trial Agreements Under Kenyan Law
3 Sep 2026, 6 min read
IP Due Diligence in Life Sciences Deals: What Kenyan Investors and Acquirers Should Check
3 Sep 2026, 6 min read
Mergers and Acquisitions in Kenya’s Healthcare Sector: A Legal Due Diligence Guide
3 Sep 2026, 6 min read
Software as a Medical Device: Where Kenya’s Current Framework Falls Short
2 Sep 2026, 5 min read
Regulating AI-Enabled Medical Devices: A Preview of What’s Coming to the PPB
2 Sep 2026, 4 min read
mRNA Technology Transfer: Legal Lessons for Kenya from the Afrigen and WHO Hub Programmes
2 Sep 2026, 5 min readNeed advice on Life Sciences andamp; Healthcare?
Tell us what you are dealing with. You will know what it involves and what it will cost before you commit to anything.